For example, in prostate cancer mouse models, intermittent PI3K inhibition was able to alleviate PTEN-null cancer cell-intrinsic immunosuppressive activity and turn “cold” tumours into T cell-inflamed ones[127]. Here, PTEN is linked to prostate carcinoma.